Increased levels of soluble CD14 in sera of periodontitis patients

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 417-420

  Hayashi, Joichiro ^a   Masaka, Tamami ^a   Ishikawa, Isao ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; INFLAMMATION; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; SERUM;

EID: 0032950537     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.417-420.1999     Document Type: Article

References (33)

1. Arditi, M., J. Zhou, R. Dorio, G. W. Rong, S. M. Goyert, and K. S. Kim. 1993. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61:3149-3156.
2. Arditi, M., J. Zhou, M. Torres, D. L. Durden, M. Stins, and K. S. Kim. 1995. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J. Immunol. 155:3994-4003.
3. Bazil, V., M. Baudys, I. Hilgert, I. Stefanova, M. G. Low, J. Zbrozek, and V. Horejsi. 1989. Structure relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:657-662.
4. Bazil, V., V. Horejsi, M. Baudys, H. Kristofova, J. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterization of soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-1589.
5. Beck, J., R. Gorcia, G. Heiss, P. S. Vokonas, and S. Offenbacher. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67:1123-1137.
6. Burgmann, H., S. Winkler, G. J. Locker, E. Presterl, K. Laczika, T. Staudinger, S. Knapp, F. Thalhammer, C. Wenisch, L. K. Zedwitz, M. Frass, and W. Graninger. 1996. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin. Immunol. Immunopathol. 80:307-310.
7. Camussi, G., F. Mariano, L. Biancone, M. A. De, B. Bussolati, G. Montrucchio, and P. S. Tobias. 1995. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J. Immunol. 155:316-324.
8. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
9. Hayashi, J., T. Masaka, I. Saito, and I. Ishikawa. 1996. Soluble CD14 mediates lipopolysaccharide-induced intercellular adhesion molecule 1 expression in cultured human gingival fibroblasts. Infect. Immun. 64:4946-4951.
10. Hayashi, J., I. Saito, I. Ishikawa, and N. Miyasaka. 1994. Effects of cytokines and periodontopathic bacteria on the leukocyte function-associated antigen 1/intercellular adhesion molecule 1 pathway in gingival fibroblasts in adult periodontitis. Infect. Immun. 62:5205-5212.
11. Haziot, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
12. Koehler, M., R. Goorha, G. R. Kitchingman, G. D. Ayers, and J. J. Mirro. 1992. A monoclonal antibody to a novel surface antigen. MKW, blocks the antiproliferative and differentiation effects of granulocyte-macrophage colony-stimulating factor and vitamin D3. Blood 80:367-373.
13. Kruger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Muller, J. Knoller, M. Koller, W. Konig, and W. Schonfeld. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297-301.
14. Landmann, R., H. P. Knopf, S. Link, S. Sansano, R. Schumann, and W. Zimmerli. 1996. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect. Immun. 64:1762-1769.
15. Landmann, R., W. Zimmerli, S. Sansano, S. Link, A. Hahn, M. P. Glauser, and T. Calandra. 1995. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171:639-644.
16. Loesche, W. J., and D. E. Lopatin. 1998. Interactions between periodontal disease, medical diseases and immunity in the older individual. Periodontol. 2000 16:80-105.
17. Nockher, W. A., L. Bergmann, and J. E. Scherberich. 1994. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98:369-374.
18. Nockher, W. A., and J. E. Scherberich. 1995. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int. 48:1469-1476.
19. Nockher, W. A., R. Wigand, W. Schoeppe, and J. E. Scherberich. 1994. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 96:15-19.
20. Oberg, F., J. Botling, and K. Nilsson. 1993. Functional antagonism between vitamin D, and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J. Immunol. 150:3487-3495.
21. Offenbacher, S., V. Katz, G. Fertik, J. Collins, D. Boyd, G. Maynor, R. McKaig, and J. Beck. 1996. Periodontal infection as a possible risk factor for preterm low birth weight. J. Periodontol. 67:1103-1113.
22. Pugin, J., M. C. Schurer, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748.
23. Rams, T. E., and J. Slots. 1992. Systemic manifestations of oral infections, p. 500-510. In J. Slots and M. A. Taubman (ed.). Contemporary oral microbiology and immunology. Mosby-Year Book, Inc., St. Louis. Mo.
24. Read, M. A., S. R. Cordle, R. A. Veach, C. D. Carlisle, and J. Hawiger. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 90:9887-9891.
25. Schei, O., J. Waerhaug, A. Lovdal, and A. Arno. 1959. Alveolar bone loss as related to oral hygiene and age. J. Periodontol. 30:7-16.
26. Schwartz, J., F. L. Stinson, and R. B. Parker. 1972. The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J. Periodontol, 43:270-276.
27. Silver, J. G., A. W. Martin, and B. C. McBride. 1977 Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J. Clin. Periodontol. 4:92-99.
28. Takada, H., J. Mihara, and I. Morisaki. 1991. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect. Immun. 59:295-301.
29. Tamura, M., M. Tokuda, S. Nagaoka, and H. Takada. 1992. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect. Immun. 60:4932-1937.
30. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
31. Wenisch, C., H. Wenisch, B. Parschalk, S. Vanijanonta, H. Burgmann, M. Exner, L. K. Zedwitz, F. Thalhammer, A. Georgopoulos, W. Graninger, and S. Looareesuwan. 1996. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin. Exp. Immunol. 105:74-78.
32. Williams, R. C. 1990. Periodontal disease. N. Engl. J. Med. 322:373-382.
33. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipupolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.